Emergent BioSolutions (EBS) shares gained more than 11% in recent Monday trading after HC Wainwright began coverage of the stock at buy with a $15 price target.
The company's trading volume stood at nearly 892,000 shares against a daily average of roughly 1.3 million.
Shares of Emergent BioSolutions were recently up 11.3% at $9.20.
Price: 9.15, Change: +0.88, Percent Change: +10.60
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。